Amasa Therapeutics focuses on developing receptor-targeted cell-based therapies aimed at addressing challenging cancer types. Their innovative approach leverages the specificity of receptor targeting to enhance the efficacy of therapeutic interventions, potentially improving patient outcomes in difficult-to-treat cancers. By utilizing advanced techniques in cell therapy, Amasa Therapeutics aims to create more effective treatment options that can better engage with cancer cells while minimizing damage to healthy tissues.

The company’s pipeline includes a range of products that are designed to harness the power of the immune system in a targeted manner. This involves engineering cells to recognize and attack cancer cells more effectively, thereby providing a promising avenue for treatment. Amasa Therapeutics is committed to advancing these technologies through rigorous research and development, with the goal of bringing novel therapies to patients who are in need of more effective cancer treatments.

United States

At Amasa Therapeutics, we pioneer cell therapy and aim to radically improve the ways we treat the most malignant tumors. Our engineered cells are designed to revolutionize patient care and solve problems within oncology that are decades old.

Amasa Therapeutics

Company Details